The fight against COVID19
23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | +0.82% | - | - | - |
| ^GSPC | +0.17% | +0.45% | +26.44% | +5515.79% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 149.91 | +0.06 | +0.04% | 16:00 GMT-4 | 4.26M | 7.59M | 360.79B |
| ABBV | AbbVie Inc. | 160.75 | +0.35 | +0.22% | 16:00 GMT-4 | 3.49M | 5.69M | 283.86B |
| PFE | Pfizer Inc. | 28.01 | -0.17 | -0.60% | 16:00 GMT-4 | 21.88M | 42.71M | 158.72B |
| SNY | Sanofi | 49.28 | +0.59 | +1.21% | 16:00 GMT-4 | 1.05M | 2.01M | 126.55B |
| REGN | Regeneron Pharmaceuticals, Inc. | 973.8 | +5.80 | +0.60% | 16:00 GMT-4 | 348.36k | 460.69k | 107.30B |
| GSK | GlaxoSmithKline plc | 45.07 | +0.40 | +0.90% | 16:00 GMT-4 | 3.65M | 3.34M | 92.71B |
| GILD | Gilead Sciences, Inc. | 65.96 | +1.38 | +2.14% | 16:00 GMT-4 | 8.71M | 7.18M | 82.18B |
| MRNA | Moderna, Inc. | 117.31 | -5.38 | -4.39% | 16:00 GMT-4 | 4.23M | 3.87M | 44.96B |
| TAK | Takeda Pharmaceutical Company Limited | 13.25 | -0.12 | -0.90% | 16:00 GMT-4 | 1.95M | 1.67M | 41.58B |
| BNTX | BioNTech SE | 91.67 | -0.39 | -0.42% | 16:00 GMT-4 | 387.97k | 602.85k | 22.09B |
| VIR | Vir Biotechnology, Inc. | 9.44 | -0.12 | -1.26% | 16:00 GMT-4 | 577.36k | 1.04M | 1.28B |
| NVAX | Novavax, Inc. | 8.88 | +4.41 | +98.66% | 16:00 GMT-4 | 170.01M | 6.83M | 1.25B |
| INO | Inovio Pharmaceuticals, Inc. | 10.65 | -0.53 | -4.74% | 16:00 GMT-4 | 228.05k | 452.69k | 289.12M |
- Yahoo Finance Video
Fed rates, Tesla Supercharger backpedal, Novavax's 'new chapter': Market Domination
On today's episode of Market Domination, Yahoo Finance Hosts Julie Hyman and Josh Lipton break down the latest earnings and major trends Wall Street analysts are eyeing. Sweetgreen (SG) shares soar after the company topped first quarter revenue estimates and raised full-year guidance. Similarly, Taiwan Semiconductor Manufacturing Company (TSM) shares are rising after the company reported that its sales jumped nearly 60% year over year, largely due to AI demand. Morgan Stanley Wealth Management Managing Director Dan Skelly joins Market Domination to discuss some signs pointing to the Fed potentially cutting interest rates several times before the end of the year. Novavax (NVAX) shares skyrocket after the company announced a $1.2 billion vaccine deal with French drugmaker Sanofi (SNY). B. Riley Securities Managing Director & Group Head of Healthcare Research Mayank Mamtani explains how the partnership marks a "new chapter" for Novavax after a post-pandemic slump. Yahoo Finance reporter Pras Subramanian joins to discuss Tesla (TSLA) CEO Elon Musk backpedaling his recent move to shrink the company's Supercharger team. As many legacy automakers signed up to participate in Tesla's Supercharger network, Subramanian says Musk is trying to fix the issue he created after laying off a majority of the Supercharger team. A new edition of Good Buy or Goodbye analyzes two companies in the finance sector: PayPal (PYPL) and Goldman Sachs (GS). This post was written by Melanie Riehl
- Yahoo Finance Video
Consumer sentiment drops, Tesla's Supercharger, Zeekr IPO: Catalysts
The University of Michigan's Consumer Sentiment Index reported that preliminary data for the month of May fell below estimates, a six-month low of 67.4, which could complicate the Federal Reserve's mission to drive inflation down to 2%. Artificial intelligence developer OpenAI is reportedly developing an AI-powered search engine that could rival Alphabet's Google (GOOGL, GOOG), and it could drop as early as Monday, May 13 according to Reuters. Path Trading Partners Co-Founder and Chief Market Strategist Bob Iaccino joins Catalysts to detail how Fed interest rate cuts and asset inflation could fuel a jump in gold futures (GC=F). Gartner Vice President and Team Manager of Automotives, Transportation, and Cross Manufacturing Mike Ramsey also sits down to explain the future of Tesla's (TSLA) Supercharger network and the EV maker's plans for its full self-driving autonomous vehicles down the line. Other notable guests this hour include Santander US CEO Tim Wennes (SAN) and Gen Digital CEO Vincent Pilette (GEN). This post was written by Luke Carberry Mogan.
- Yahoo Finance Video
Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal
Novavax (NVAX) shares are skyrocketing after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu shot. Yahoo Finance's Anjalee Khemlani joins The Morning Brief to report more on the story. The Novavax-Sanofi deal also includes co-commercialization of the COVID-19 vaccine currently on the market. Novavax will be entitled to an additional $200 million for any new vaccines involving its adjuvant. Sanofi will receive a minority stake of less than 5% in Novavax and will invest $70 million. Shares of Novavax jumped more than 120% following the news. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Melanie Riehl
